1 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Micropapillary Serous Carcinoma: new trials by email Literature Review of Micropapillary Serous Carcinoma trials Research Report on Micropapillary Serous Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer Letrozole, Paclitaxel, Pegylated Liposomal Doxorubicin Hydrochloride - Borderline Ovarian Serous Tumor, Micropapillary Serous Carcinoma | Phase 2 / Phase 3 | Completed | National Cancer Institute (NCI) | 260 | 2014-04-11 | 2026-08-04 |
Cystadenocarcinoma, Serous (1)
Adenocarcinoma (1) · Carcinoma (1) · Cystadenocarcinoma (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Cystic, Mucinous, and Serous (1) · Neoplasms, Glandular and Epithelial (1)
Doxorubicin (1) · Letrozole (1) · Paclitaxel (1) · Tamoxifen (1) · Taxes (1) · Topotecan (1) · liposomal doxorubicin (1) · trametinib (1)
National Cancer Institute (NCI) (1)
United Kingdom (1) · United States (1)
P50CA083639 (1), U10CA180868 (1)